###### Strengths and limitations of this study

-   This systematic review protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols guideline.

-   This protocol prevents the potential for duplication and allows for transparency in the research process.

-   This systematic review will be the first to synthesis the prevalence, incidence and patterns of musculoskeletal disorders from non-fatal road traffic collisions (RTC) in Africa.

-   It is hoped that findings from this review will provide evidence for policymakers and stakeholders to put in place prevention strategies to mitigate the burden associated with RTC within this region.

-   It is likely that there will be some under-reporting in the incidence of RTC within Africa.

Background {#s1}
==========

Over the past few decades, due to the dedicated attention, resources and progress, the global burden of disease has shifted from communicable diseases to non-communicable diseases and injuries.[@R1] Surpassing tuberculosis and HIV/AIDS, road traffic collisions (RTC) are the eighth leading cause of death and the number one leading cause of death for children and young adults aged between 5 and 29 years.[@R2] These rates are at their highest in Africa, where there are 26.6 deaths per 100 000 people; this is substantially high in comparison to Europe where the death rate is at its lowest (9.3 deaths per 100 000 people). Further, the WHO predicts that by 2030 injuries from RTC will be the seventh leading cause of deaths globally.[@R3]

In addition to their high mortality rates, RTC are considered a burden within those who do survive. They have a significant impact on quality of life, clinical and financial burden, and therefore are a major public health problem.[@R4] In Africa, injuries related to RTC have been identified as the 10th most common cause of disability-adjusted life years lost for all ages and categories.[@R1] Within Africa, non-fatal RTC are the biggest cause of burden associated with musculoskeletal disorders (MSD); this rate is more than the combined burden of the three big non-traumatic MSD (low back pain, osteoarthritis and rheumatoid arthritis combined).[@R7] Despite such burden, the epidemiology of MSD related to non-fatal RTC within this region is still unknown.

There has been previous research evaluating the burden of RTC in Africa,[@R8] though, there has not yet been a systematic review synthesising the epidemiology of MSD resulting from non-fatal RTC within Africa. Knowing the burden of these disorders is vital as it provides baseline data by evaluating what is already known, thus providing evidence for policymakers and stakeholders, including the WHO and the US Centers for Disease Control,[@R10] who wish to undertake prevention strategies to mitigate the burden associated with RTC within Africa.

Aims and objectives {#s1-1}
-------------------

To establish the burden associated with MSD relating to non-fatal RTC, we aim to examine the burden of MSD-related RTC, with the objective of identifying and summarising available data regarding the prevalence, incidence and patterns of MSD resulting from non-fatal RTC in the different type of road users (pedestrian, passenger, driver and cyclists) within Africa.

Methods {#s2}
=======

This systematic review protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) for Protocols statement.[@R12] Additionally, the final systematic review will be conducted as per the PRISMA guideline.[@R13]

Eligibility criteria {#s2-1}
--------------------

Studies will be included if they were conducted in an African country between 1990 and 2018, as within this period data capture reporting of non-fatal RTC is anticipated to be of good quality.[@R8] Studies that are of the following observational design will also be included: cross-sectional, prospective cohort, retrospective cohort and case control, and also if they used data from population-based or registry-based data systems. Additionally, studies should estimate the number of MSD due to non-fatal RTC in pedestrians, passengers, cyclists or drivers. Studies will be excluded if they referred to other non-road transportation systems, such as water and air, and if they were a review, opinion piece, commentary, case study and case series. If studies looked at other non-MSD, such as neurological injuries or wound infection, they will also not be included in the review.

In this review, our case definition is non-fatal injuries, including minor injuries with disabilities of short duration to severe injuries with lifelong disabilities, resulting from RTC by various road user types (pedestrians, motorised four-wheeler occupants, motorised two-wheeler and three-wheeler users, and cyclists).[@R2] Further, we define MSD as soft-tissue injuries or pain within the skeletal systems that may be associated with injury affecting muscles, bones, ligaments, cartilages and so on.[@R13]

Information sources and search strategy {#s2-2}
---------------------------------------

On October 2019, the following electronic databases will be searched for relevant literature: MEDLINE, Embase, CINAHL Plus, PsycINFO, Web of Science, Global Health and African Journals OnLine. With the help of the University librarian, a search strategy will be set in place; the key search concepts will be road traffic collision and injuries, Africa, observational data design and musculoskeletal injuries---see [online supplementary file 1](#SP1){ref-type="supplementary-material"} for full search terms. Two reviewers (MY and TG) will initially execute the search strategy. Search results will be limited to the English language.
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Study selection {#s2-3}
---------------

All the abstracts found in the search results will be pooled and managed in Zotero referencing software, after that duplicates will be removed from this list. Two reviewers (MY and TG) will evaluate the titles and abstracts of the search results against the prespecified extraction criteria. Subsequently, both reviewers will independently screen the full articles against the eligibility criteria, any disagreements between the two reviewers will be resolved by the third reviewer (FF) through a discussion.

Data collection process {#s2-4}
-----------------------

Based on the extraction list, two reviewers (MY and TG) will independently extract the relevant data into an Excel spreadsheet (V.2016, Microsoft). Both reviewers will independently cross-check extracted data, if consensus is not reached, then a third reviewer (FF) will resolve discrepancies between the two reviewers through discussion.

Once the eligible studies are finalised, the quality of studies will be appraised by two reviewers (MY and TG) using the US National Institutes of Health National Heart, Lung, and Blood Institute Quality Assessment Tool (NIH, 2014). This widely used assessment tool determines the quality of observational studies. In the form of questions, there are 12--14 items within the appraisal tool. These include sample size, population sampling, follow-up period, measurements and outcomes of interest. Independently, reviewer 1 and 2 (MY and TG) will subjectively determine the presence of these elements; potential answers for the questions include yes, no or other (cannot determine, not applicable or not reported). If there is no consensus between the two reviewers, then a third reviewer (FF) will resolve discrepancies through a discussion. The summary of each study will be calculated and expressed as a percentage. The interpretation for the scale will be categorised into four groups: poor (0%--25%), fair (25%--50%), good (50%--75%) or excellent (75%--100%).

### Data items {#s2-4-1}

There will be four categories of extracted data, this includes data on citation, study, methods and results (see [box 1](#B1){ref-type="boxed-text"} for extraction list and coding system). In the citation category, data on title, lead author, year of publication and journal will be extracted. For the study section, study aims or goals will be extracted. For the methods section, country of study, study design, study period, sample size and case definition will be extracted. Data extraction in the results section involves extracting data related to the reported RTC, this involves participation rate, demographics of the included cohort and total number of non-fatal RTC (per vehicle, per road users and per demographics). Additionally, data on prevalence, incidence and disease pattern of MSD will be extracted, and if available, data on the determinants of RTC will also be extracted. Data will be grouped by country of study, year, age, sex, type of MSD and type of RTC determinant. We define prevalence as the proportion of individuals in a population who have non-fatal RTC-related MSD in a specific time period, while incidence rate is the number of new cases who have non-fatal RTC-related MSD during a certain period of time.[@R14]

###### Extraction list and coding system

-   Citation

    a.  Title of article

    b.  Lead author

    c.  Year published

    d.  Journal

-   Study

    a.  Aims/goals/objectives

-   Methods

    a.  Country of study

    b.  Study design

    c.  Study period

    d.  Sample size

    e.  Case definition

-   Results

    a.  Participation rate

    b.  Demographics of included cohort

    c.  Total number of non-fatal road traffic collisions (by subgroups)

    d.  Prevalence, incidence and disease patterns of musculoskeletal disorders

### Analysis {#s2-4-2}

Extracted data will be analysed using a narrative synthesis. Findings will be presented in tables, with the main outcomes being prevalence, incidence and disease pattern of MSD. Further, data will be grouped by country of study, year, age, sex and type of MSD.

Ethics and dissemination {#s2-5}
------------------------

As individual patients will not be involved in this study, no ethical approval will be sought. Findings from this review will be disseminated through peer-reviewed journals and relevant conferences.

Patient and public involvement {#s2-6}
------------------------------

There was no patient or public involvement in any phase of this study, this included the development of the research question, the analysis and the conclusions.

Discussion {#s3}
==========

This systematic review will provide a synthesis of the current evidence pertaining to the prevalence and incidence of non-fatal RTC in Africa. Conclusion drawn from this is envisaged to inform future policies and public health prevention strategies to minimise the burden related to RTC in Africa. This review has some limitations. First, it is likely that there will be some under-reporting in the incidence of RTC within Africa.[@R8] Second, it is likely that studies will be heterogeneous in quality and design.
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